Scientific and innovative

About Almirall, LLC - U.S.

Noble purpose

Almirall, LLC is a global dermatology pharmaceutical company headquartered in Barcelona, Spain. For nearly 80 years, we’ve pioneered and launched innovative prescription medicines that help patients today in over 70 countries.

Our mission and noble purpose is to transform the patients’ world by helping them improve their skin and realize their hopes and dreams for a healthy life.

Company details

Almirall, LLC - U.S. is headquartered in Malvern, Pennsylvania. Our acne, actinic keratosis, dermatitis, and impetigo therapies are trusted by healthcare professionals and patients nationwide.

Our top-selling brands in the United States include: SEYSARA® (sarecycline) Tablets and KLISYRI® (tirbanibulin) 1% Ointment.

Leadership team

The professional experience, educational preparation, energy, and enthusiasm of our US leadership team helps to explain our success.

Pablo Alvarez

President and General Manager of Almirall, LLC - U.S.

20+ years of pharmaceutical experience at Almirall, AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline. PhD in Microbiology and Post Doctorate in Cell Biology.

Bonnie Bouchard

Chief Financial Officer

20+ years of pharmaceutical experience at AmerisourceBergen, Teva Pharmaceuticals, and Pfizer. MS in Pharmacy and BA in Accountancy.

Vincent Cerio

Head of Commercial Operations

20+ years of pharmaceutical experience at Insmed, Purdue, Otsuka, Novo Nordisk, and Novartis. MBA in Accounting and BS in Economics and Business Management.

Biju Chorinchath

Executive Director and Head of Marketing, Market Access, and Business Development

20+ years of pharmaceutical experience at CSL Behring, Sobi, and Pfizer. MS in Health Policy and Management.

Domenick Dicindio

Senior Director, Human Resources

30+ years of pharmaceutical experience at Almirall, Novartis, and Winthrop. MBA in Marketing and a BS in Business with an emphasis in Economics.

Glenn Cantagallo

National Sales Director

20+ years of pharmaceutical and medical device experience at Novo Nordisk and Abbott Laboratories. BA in Biology and Certificate of Development from Wharton.

Financial reports

Almirall is a public company listed on the BME Spanish stock exchange.

View our annual and other financial reports at Almirall.com/investors.

For business development and partnership opportunities, please email Biju Chorinchath: biju.chorinchath@almirall.com.